Analysis of TP53 mutations from 1,420 tumor samples revealed that loss of one TP53 allele may be a sufficient driver in breast cancers of the luminal B subtype as a higher fraction of wild-type tumors with LOH is noticed [99]. The gene discussed is TP53; the disease is neoplasm.